ASG. Aurora Spine Corp

Aurora Spine Postpones and Reschedules Annual Meeting of Shareholders

Aurora Spine Postpones and Reschedules Annual Meeting of Shareholders

CARLSBAD, Calif., June 17, 2020 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSX VENTURE:ASG) announced today that given the extraordinary circumstances of the ongoing COVID-19 pandemic and the resulting restrictions on public gatherings, it is postponing its annual meeting of shareholders to August 11, 2020 in Toronto, Canada.

The Company is assessing its options to include telephonic participation with a view to protecting the health and safety of its employees, shareholders, and other usual meeting attendees. As a result, the current meeting and record dates are cancelled. The updated record date is July 6, 2020.

Investor Relations Engagement

The Company also announces that it has entered into an agreement with Lytham Partners, LLC ("Lytham"), whereby Lytham will provide investor relations services to the Company on a quarter by quarter basis with automatic renewals, unless the agreement is terminated by either party in accordance with the terms thereof. Lytham, based in Phoenix, Arizona, is arm's length to the Company and has experience with providing investor relations services to junior public companies. The services to be provided to the Company by Lytham include investor outreach activities, assistance on corporate communications and capital markets advisory services. The Company will pay to Lytham a quarterly fee of USD$22,500, subject to early payment credit, plus reasonable out of pocket expenses incurred by Lytham. Other than Adam Lowensteiner, the Vice President of Lytham, who owns less than 1% of the outstanding common shares of Aurora Spine, Lytham, its directors and officers, and the authorized individuals at Lytham acting on behalf of Aurora Spine, do not, directly or indirectly, own any securities of the Company or any right to securities of the Company and have no intention of acquiring such interest. The engagement is subject to TSX Venture Exchange approval.

About Aurora Spine

Aurora Spine is an early stage company focused on bringing new solutions to the spinal implant market through a series of screwless, innovative, minimally invasive, regenerative spinal implant technologies. Aurora Spine continues to position itself at the forefront of spinal surgery procedures, focusing on minimally invasive spine surgery technologies. Aurora Spine is changing spine surgery by focusing on disruptive technologies following the Company’s commitment to – Simplifying the Complex.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For more information, please contact:

Aurora Spine Corporation

Trent Northcutt

President and Chief Executive Officer

(760) 424-2004

Jana F. Kiena

Chief Financial Officer

(760) 424-2004

          

 

EN
18/06/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Aurora Spine Corp

 PRESS RELEASE

Aurora Spine Corporation Announces Record Third Quarter Financial Resu...

Aurora Spine Corporation Announces Record Third Quarter Financial Results - Company to host conference call Today, November 18th at 11am ET/8am PT – NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in minimally invasive spine and interventional pain solutions, today announced its financial results for third quarter ended September 30, 2025. All figures are in U.S. dollars. Financial and Business Highlights ...

 PRESS RELEASE

Aurora Spine Corporation Announces Participation at the North American...

Aurora Spine Corporation Announces Participation at the North American Spine Society Annual Meeting Company to Showcase Cutting-Edge Innovations at Booth #1622  CARLSBAD, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a leader in the development of groundbreaking medical devices for spinal surgery, today announced its participation at the 2025 North American Spine Society ("NASS") Annual Meeting. The event will take place from November 14-16, 2025, at the Colorado Convention Center, in Denver, Colorado. A...

 PRESS RELEASE

Aurora Spine Launches New Biologics Portfolio

Aurora Spine Launches New Biologics Portfolio New Aurora Biologics Division Establishes Aurora Spine as a Vertically Integrated Source for Spinal Implants and Biologics CARLSBAD, CA, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine”) (TSXV: ASG) (OTCQB: ASAPF), a leader in minimally invasive spine and interventional pain solutions, today announced the launch of Aurora Biologics, a new division dedicated to advancing spinal fusion success through best-in-class biologic innovation. The establishment of Aurora Biologics creates seamless synergy across Aurora’s gr...

 PRESS RELEASE

Aurora Spine Announces Proposed Warrant Extension

Aurora Spine Announces Proposed Warrant Extension CARLSBAD, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in innovative spine and interventional pain management solutions, today announces that, subject to the approval of the TSX Venture Exchange,  it is proposing to amend the terms of an aggregate of 6,445,939 common share purchase warrants (the “Warrants”) by extending the expiry date of the Warrants until October 15, 2026. The Warrants, with an exercise price of CDN$0.50 and an original expiry...

 PRESS RELEASE

Aurora Spine Announces Launch of its DEXA-L™ Anterior Lumbar Interbody...

Aurora Spine Announces Launch of its DEXA-L™ Anterior Lumbar Interbody Fusion Device CARLSBAD, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in innovative spine and interventional pain management solutions, today announces the official launch of its DEXA-L™ Anterior Lumbar Interbody Fusion Device, with the product being implanted in recent initial surgeries. DEXA-L is part of Aurora’s patented DEXA™ Technology Platform, which is a series of products that are the world’s first bone density ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch